Sabin Vaccine Institute (Sabin) announced receipt of a four-year, €5.9 million grant from the Netherlands Ministry of Foreign Affairs to support the development of a vaccine to combat human hookworm infection.
Hookworm infection, an intestinal parasitic disease most commonly found in sub-Saharan Africa, Southeast Asia and Latin America, affects an estimated 600 million people.





